Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study.
Timothy R BettsMarek GrygierJens Erik Nielsen KudskThomas SchmitzMarcus SandriGavino CasuMartin W BergmannDavid Hildick-SmithThomas ChristenDominic J Allocconull nullPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
The WATCHMAN FLX device had excellent procedural success rates, high LAA seal rates, and low rates of thromboembolic events in everyday clinical practice.